The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bortezomib API Market Research Report 2025
Synopsis
It is white solid in appearance, CAS number is 179324-69-7, and the molecular formula is C19H25BN4O4.
The global Bortezomib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bortezomib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bortezomib API.
Report Scope
The Bortezomib API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bortezomib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bortezomib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Scion Pharm Taiwan
Farmhispania Group
Tapi Teva
Shilpa Medicare Limited
Dr. Reddy's Laboratories
Gland Chemicals
Icrom
Vinkem Labs
Qilu Pharmaceutial
Chem-Stone(Guangzhou)
Chengdu Aslee Biopharmaceuticals
Coresyn
Hubei Honch Pharmaceutical
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Injection
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bortezomib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bortezomib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bortezomib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
It is white solid in appearance, CAS number is 179324-69-7, and the molecular formula is C19H25BN4O4.
The global Bortezomib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bortezomib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bortezomib API.
Report Scope
The Bortezomib API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bortezomib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bortezomib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Scion Pharm Taiwan
Farmhispania Group
Tapi Teva
Shilpa Medicare Limited
Dr. Reddy's Laboratories
Gland Chemicals
Icrom
Vinkem Labs
Qilu Pharmaceutial
Chem-Stone(Guangzhou)
Chengdu Aslee Biopharmaceuticals
Coresyn
Hubei Honch Pharmaceutical
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Injection
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bortezomib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bortezomib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bortezomib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Bortezomib API Market Overview
1.1 Product Definition
1.2 Bortezomib API Segment by Type
1.2.1 Global Bortezomib API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Bortezomib API Segment by Application
1.3.1 Global Bortezomib API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Injection
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Bortezomib API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Bortezomib API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Bortezomib API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Bortezomib API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Bortezomib API Production Market Share by Manufacturers (2019-2024)
2.2 Global Bortezomib API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Bortezomib API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Bortezomib API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Bortezomib API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Bortezomib API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Bortezomib API, Product Offered and Application
2.8 Global Key Manufacturers of Bortezomib API, Date of Enter into This Industry
2.9 Bortezomib API Market Competitive Situation and Trends
2.9.1 Bortezomib API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Bortezomib API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Bortezomib API Production by Region
3.1 Global Bortezomib API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Bortezomib API Production Value by Region (2019-2030)
3.2.1 Global Bortezomib API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Bortezomib API by Region (2025-2030)
3.3 Global Bortezomib API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Bortezomib API Production by Region (2019-2030)
3.4.1 Global Bortezomib API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Bortezomib API by Region (2025-2030)
3.5 Global Bortezomib API Market Price Analysis by Region (2019-2024)
3.6 Global Bortezomib API Production and Value, Year-over-Year Growth
3.6.1 North America Bortezomib API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Bortezomib API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Bortezomib API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Bortezomib API Production Value Estimates and Forecasts (2019-2030)
4 Bortezomib API Consumption by Region
4.1 Global Bortezomib API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Bortezomib API Consumption by Region (2019-2030)
4.2.1 Global Bortezomib API Consumption by Region (2019-2024)
4.2.2 Global Bortezomib API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Bortezomib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Bortezomib API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Bortezomib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Bortezomib API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Bortezomib API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Bortezomib API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Bortezomib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Bortezomib API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Bortezomib API Production by Type (2019-2030)
5.1.1 Global Bortezomib API Production by Type (2019-2024)
5.1.2 Global Bortezomib API Production by Type (2025-2030)
5.1.3 Global Bortezomib API Production Market Share by Type (2019-2030)
5.2 Global Bortezomib API Production Value by Type (2019-2030)
5.2.1 Global Bortezomib API Production Value by Type (2019-2024)
5.2.2 Global Bortezomib API Production Value by Type (2025-2030)
5.2.3 Global Bortezomib API Production Value Market Share by Type (2019-2030)
5.3 Global Bortezomib API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Bortezomib API Production by Application (2019-2030)
6.1.1 Global Bortezomib API Production by Application (2019-2024)
6.1.2 Global Bortezomib API Production by Application (2025-2030)
6.1.3 Global Bortezomib API Production Market Share by Application (2019-2030)
6.2 Global Bortezomib API Production Value by Application (2019-2030)
6.2.1 Global Bortezomib API Production Value by Application (2019-2024)
6.2.2 Global Bortezomib API Production Value by Application (2025-2030)
6.2.3 Global Bortezomib API Production Value Market Share by Application (2019-2030)
6.3 Global Bortezomib API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Scion Pharm Taiwan
7.1.1 Scion Pharm Taiwan Bortezomib API Corporation Information
7.1.2 Scion Pharm Taiwan Bortezomib API Product Portfolio
7.1.3 Scion Pharm Taiwan Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Scion Pharm Taiwan Main Business and Markets Served
7.1.5 Scion Pharm Taiwan Recent Developments/Updates
7.2 Farmhispania Group
7.2.1 Farmhispania Group Bortezomib API Corporation Information
7.2.2 Farmhispania Group Bortezomib API Product Portfolio
7.2.3 Farmhispania Group Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Farmhispania Group Main Business and Markets Served
7.2.5 Farmhispania Group Recent Developments/Updates
7.3 Tapi Teva
7.3.1 Tapi Teva Bortezomib API Corporation Information
7.3.2 Tapi Teva Bortezomib API Product Portfolio
7.3.3 Tapi Teva Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Tapi Teva Main Business and Markets Served
7.3.5 Tapi Teva Recent Developments/Updates
7.4 Shilpa Medicare Limited
7.4.1 Shilpa Medicare Limited Bortezomib API Corporation Information
7.4.2 Shilpa Medicare Limited Bortezomib API Product Portfolio
7.4.3 Shilpa Medicare Limited Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Shilpa Medicare Limited Main Business and Markets Served
7.4.5 Shilpa Medicare Limited Recent Developments/Updates
7.5 Dr. Reddy's Laboratories
7.5.1 Dr. Reddy's Laboratories Bortezomib API Corporation Information
7.5.2 Dr. Reddy's Laboratories Bortezomib API Product Portfolio
7.5.3 Dr. Reddy's Laboratories Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.6 Gland Chemicals
7.6.1 Gland Chemicals Bortezomib API Corporation Information
7.6.2 Gland Chemicals Bortezomib API Product Portfolio
7.6.3 Gland Chemicals Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Gland Chemicals Main Business and Markets Served
7.6.5 Gland Chemicals Recent Developments/Updates
7.7 Icrom
7.7.1 Icrom Bortezomib API Corporation Information
7.7.2 Icrom Bortezomib API Product Portfolio
7.7.3 Icrom Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Icrom Main Business and Markets Served
7.7.5 Icrom Recent Developments/Updates
7.8 Vinkem Labs
7.8.1 Vinkem Labs Bortezomib API Corporation Information
7.8.2 Vinkem Labs Bortezomib API Product Portfolio
7.8.3 Vinkem Labs Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Vinkem Labs Main Business and Markets Served
7.7.5 Vinkem Labs Recent Developments/Updates
7.9 Qilu Pharmaceutial
7.9.1 Qilu Pharmaceutial Bortezomib API Corporation Information
7.9.2 Qilu Pharmaceutial Bortezomib API Product Portfolio
7.9.3 Qilu Pharmaceutial Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Qilu Pharmaceutial Main Business and Markets Served
7.9.5 Qilu Pharmaceutial Recent Developments/Updates
7.10 Chem-Stone(Guangzhou)
7.10.1 Chem-Stone(Guangzhou) Bortezomib API Corporation Information
7.10.2 Chem-Stone(Guangzhou) Bortezomib API Product Portfolio
7.10.3 Chem-Stone(Guangzhou) Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Chem-Stone(Guangzhou) Main Business and Markets Served
7.10.5 Chem-Stone(Guangzhou) Recent Developments/Updates
7.11 Chengdu Aslee Biopharmaceuticals
7.11.1 Chengdu Aslee Biopharmaceuticals Bortezomib API Corporation Information
7.11.2 Chengdu Aslee Biopharmaceuticals Bortezomib API Product Portfolio
7.11.3 Chengdu Aslee Biopharmaceuticals Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Chengdu Aslee Biopharmaceuticals Main Business and Markets Served
7.11.5 Chengdu Aslee Biopharmaceuticals Recent Developments/Updates
7.12 Coresyn
7.12.1 Coresyn Bortezomib API Corporation Information
7.12.2 Coresyn Bortezomib API Product Portfolio
7.12.3 Coresyn Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Coresyn Main Business and Markets Served
7.12.5 Coresyn Recent Developments/Updates
7.13 Hubei Honch Pharmaceutical
7.13.1 Hubei Honch Pharmaceutical Bortezomib API Corporation Information
7.13.2 Hubei Honch Pharmaceutical Bortezomib API Product Portfolio
7.13.3 Hubei Honch Pharmaceutical Bortezomib API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Hubei Honch Pharmaceutical Main Business and Markets Served
7.13.5 Hubei Honch Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Bortezomib API Industry Chain Analysis
8.2 Bortezomib API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Bortezomib API Production Mode & Process
8.4 Bortezomib API Sales and Marketing
8.4.1 Bortezomib API Sales Channels
8.4.2 Bortezomib API Distributors
8.5 Bortezomib API Customers
9 Bortezomib API Market Dynamics
9.1 Bortezomib API Industry Trends
9.2 Bortezomib API Market Drivers
9.3 Bortezomib API Market Challenges
9.4 Bortezomib API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
